The immune suppressive effect of dexamethasone in rheumatoid arthritis is accompanied by upregulation of interleukin 10 and by differential changes in interferon γ and interleukin 4 production

Annals of the Rheumatic Diseases

Volumn 58, Issue 1, 1999, Pages 49-54

  Verhoef, M ^a   Van Roon, J A G ^a   Vianen, M E ^a   Lafeber, F P J G ^a   Bijlsma, J W J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA;

ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STEROID THERAPY; T LYMPHOCYTE SUBPOPULATION;

EID: 0033061274     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.1.49     Document Type: Article

References (39)

1. Romagnani S. Biology of human Th1 and Th2 cells. J Clin Immunol 1995;15:121-9.
2. Mosmann TR, Sad S. The expanding universe of T cell subsets: Th1, Th2 and more. Immumol Today 1996;17: 138-46.
3. Wilbrink B, Holewijn M, Bijlsma JWJ, Van Roy JCAM, Den Otter W, Van Eden W. Suppression of human cartilage proteoglycan synthesis by rheumatoid synovial fluid mononuclear cells activated with mycobacterial 60 kd heat shock protein. Arthritis Rheum 1993:36:514-18.
4. Schulze-Koops H, Lipsky PE, Kavanaugh AF, David LS. Elevated Th1-or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. J Immunol 1995;155:5029-37.
5. Dolhain RJEM, Van Der Heiden AN, Ter Haar NT, Breedveld FC, Miltenburg AMM. Shift towards T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheum 1996; 39:1961-9.
6. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitits of rheumatoid arthritis. Arthritis Rheum 1992;35:729-35.
7. Van Roon JAG, Van Roy JLAM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Prevention and reversal of cartilage degradation in rheumatoid arthritis by interleukin-10 and interleukin-4. Arthritis Rheum 1996;39:829-35.
8. Van Roon JAG, Verhoef CM, Gmelig-Meyling FHJ, Lafeber FPJG, Bijlsma JWJ. Peripheral type 1/ type 2 T cell cytokine production in RA correlates with erythrocyte sedimentation rate and radiographic joint damage. Ann Rheum Dis 1997;56:656-60.
9. Joosten LAB, Lubberts E, Durez P, Helsen MMA, Jacobs MJM, Goldman M, et al. The role of IL-4 and IL-10 in the regulation of murine collagen induced arthritis. Arthritis Rheum 1997;40:249-60.
10. Verhoef CM, Van Roon JAG, Vianen ME, Bruinzeel-Koomen CAFM, Lafeber FPJG, Bijlsma JWJ. Mutual antagonism of rheumatoid arthritis and hayfever; a role for type 1 / type 2 T cell balance. Ann Rheum Dis 1998;57:275-80.
11. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
12. Katsikis PD, Chu CQ, Brennan FB, Maini RN, Feldmann M. Immunoregulatory role of interleukin 10 (IL-10) in rheumatoid arthritis. J Exp Med 1994;179:1517-27.
13. Cush JJ, Splawski JB, Thomas R, McFarlin JE, Schulze-Koops H, Davis LS, et al. Elevated Interleukin-10 levels in patients with rheumatoid arthritis. Arthtritis Rheum 1995; 38:96-104.
14. Rousset F, Garcia E, Deference T, Peronne C, Vezzio N, Hsu DH, et al. IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci 1994;89:1890-3.
15. Maini RN, Paulus H, Breedveld FC, Moreland LW, William St Clair E, et al. rhuIL-10 in subjects with active rheumatoid arthritis (RA): a phase 1 and cytokine study. Arthritis Rheum 1997;40:S224.
16. Bijlsma JWJ, Van Everdingen AA, Jacobs JWG. Corticosteroids in rheumatoid arthritis. How best to use them? Clin Immunother 1995;4:271-86.
17. Smith MD, Ahern MJ, Roberts-Thompson PJ. Pulse methylprednisolone therapy in rheumatoid arthritis: Unproved therapy, unjustified therapy, or effective adjunctive treatment? Ann Rheum Dis 1990;49:265-7.
18. Weusten BCAM, Jacobs JWG, Bijlsma JWJ. Short-term and long-term complications of corticosteroid pulse therapy in rheumatoid arthritis. Semin Arthritis Rheum 1993;23: 183-92.
19. Harbuz MS, Stephanou A, Sarlis N, Lightman SL. The effect of recombinant human interleukin (IL)-1α , IL-1β or IL-6 on hypothalamo-pituitary-adrenal axis activation. J Endocrinol 1992;133:349-55.
20. Lyson K, McCann SM. The effect of Interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 1992;54:262-6.
21. Norbiato G, Bevilacqua M, Vago T, Lerici M. Glucocorticoids and Th-1, Th-2 type cytokines in rheumatoid arthritis, osteoarthritis, asthma, atopic dermatitis and AIDS. Clin Exp Rheumatatol 1997;15:315-23.
22. 22 Brink HR van den, Wijk MJG van, Geertzen RGM, Bijlsma JWJ. Influence of corticosteroid pulse therapy on the serum levels of soluble IL-2 receptor, IL-6 and IL-8 in patients with rheumatoid arthritis. J Rheumatol 1994;21:430-4.
23. Bertouch JV, Roberts-Thompson PJ, Smith MD, Woodruff TG, Brooks PM, Bradley J. Methylprednisolone infusion therapy in rheumatoid arthritis patients. The effect on synovial fluid lymphocyte subsets and inflammatory indices. Arthritis Rheum 1986;29:32-8.
24. Daynes RA, Araneo BA. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol 1989; 19: 2319-25.
25. Arya SK, Wong-Staal F, Gallo RC. Dexamethasone mediated inhibition of human T cell growth factor and γ-interferon messenger RNA. J Immunol 1984;133:273-6.
26. + subsets. J Immunol 1995;155:3322-8.
27. Tabardel Y, Duchateau J, Schmartz D, Marcecaux G, Shahla M, Barvais L, et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 1996;119:76-80.
28. Youssef PP, Haynes DR, Triantafillou S, Parker A, Gamble JR. Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid and synovial membrane in rheumatoid arthritis. Arthritis Rheum 1997; 40:1400-8.
29. Rook GAW, Hernandez-Pando R, Lightman SL. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol Today 1994;15:301-3.
30. Snijdewint FGM, Kapsenberg ML, Wauben-Penris PJJ, Bos JD. Corticosteroids class-dependently inhibit in vitro Th1-and Th2-type cytokine production. Immunopharmacology 1995;29:93-101.
31. Crabtree GR, Gillis S, Smith KA, Munck A. Glucocorticoids and immune responses. Arthritis Rheum 1979;22: 1246-56.
32. + T cells in vitro. J Immunol 1996;156:2406-12.
33. Thompson PW, Silman A, Kirwan JR, Currey HLF. Articular indices of joint inflammation in rheumatoid arthritis. Arthritis Rheum 1987;30:618-23.
34. American Rheumatism Association. Dictionary of the rheumatic diseases. Vol 1. Division ARA functional class. New York: Contact Associates International, 1988.
35. Van der Pouw-Kraan T, Van Kooten C, Rensink I, Aarden L. Interleukin-4 production by human T cells. Eur J Immunol 1992;22:1237-41.
36. June CH, Bluestone JA, Nadler LM, Thompson LB. The B7 and CD 28 receptor families. Immunol Today 1994;15: 321-31.
37. Zieg G, Lack G, Harbeck RJ, Gelfland EW, Leung DYM. In vivo effect of glucocorticoids on IgE production. J Allergy Clin Immunol 1994;94:222-30.
38. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, et al. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 1992;175:637-46.
39. Youssef PP, Triantafillou S, Parker A, Coleman M, Roberts-Thompson PJ, Ahern MJ, et al. Effects of pulse methylprednisolone on cell adhesion molecules in the synovial membrane in rheumatoid arthritis. Arthritis Rheum 1996; 39:1970-9.